🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Amicogen, Inc. (KOSDAQ:092040)
South Korea flag South Korea · Delayed Price · Currency is KRW
886.00
-60.00 (-6.34%)
Nov 20, 2026, 3:30 PM KST

Amicogen Revenue

Amicogen had revenue of 11.54B KRW in the quarter ending September 30, 2026, with 13.76% growth. This brings the company's total for the last twelve months to 48.08B, down -45.34% year-over-year. In the year 2025, Amicogen had annual revenue of 41.98B, down -75.82%. That makes Amicogen the 30,322nd largest company in the world by revenue and 1,895th in South Korea.

Revenue (ttm)
48.08B
Revenue Growth
-45.34%
P/S Ratio
1.30
Revenue / Employee
220.56M
Employees
218
Market Cap
62.42B

Revenue Chart

Revenue by Segment

By Segment

Chart
  • Raw Drug Substance 122.31B 69.1%
  • Special Enzymes, New Bio Materials, Biopharmaceutical Material, Health and Beauty 54.72B 30.9%

By Geography

Chart
  • Overseas 146.97B 84.7%
  • South Korea 26.64B 15.3%
Fiscal year ended Dec 31, 2024 See the full Amicogen breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202541.98B-131.62B-75.82%
Dec 31, 2024173.60B13.70B8.57%
Dec 31, 2023159.90B15.61B10.82%
Dec 31, 2022144.30B19.41B15.55%
Dec 31, 2021124.88B9.02B7.79%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.